| Schedule of account payable and accrued expenses |
|
|
|
|
|
|
|
|
| |
|
July 31,
2025 |
|
|
October 31,
2024 |
|
| Accrued payroll related liabilities |
|
$ |
667,000 |
|
|
$ |
667,000 |
|
| Lab equipment and supplies payables |
|
|
369,000 |
|
|
|
54,000 |
|
| Clinical trial and research payables |
|
|
653,000 |
|
|
|
648,000 |
|
| Legal fees payable |
|
|
250,000 |
|
|
|
127,000 |
|
| Other professional fees payable |
|
|
167,000 |
|
|
|
119,000 |
|
| Interest payable |
|
|
48,000 |
|
|
|
5,000 |
|
| Royalty payable |
|
|
100,000 |
|
|
|
- |
|
| Accrued commissions payable |
|
|
25,000 |
|
|
|
18,000 |
|
| Construction payables |
|
|
9,000 |
|
|
|
9,000 |
|
| Other payables and accrued expenses |
|
|
134,000 |
|
|
|
72,000 |
|
| Total Accounts Payable and Accrued Expenses |
|
$ |
2,422,000 |
|
|
$ |
1,719,000 |
|